Upperton Pharma Solutions

Upperton Pharma Solutions Advancing Oral Vaccines Delivery with Oxford’s Pandemic Sciences Institute

14 August 2025 — Nottingham, UK — Upperton Pharma Solutions, a leading UK-based contract development and manufacturing organisation (CDMO), has been awarded a grant as part of the first VaxHub Sustainable Platform Funding Call, in collaboration with the University of Oxford. The funding supports the development of an oral formulation for Adenovirus-vectored vaccines. The project, led by Professor…

Upperton Continues Strategic Growth with the Appointment of Michael Mellor-Clark as Chief Commercial Officer.

9 April 2025 – Nottingham, UK – Upperton Pharma Solutions, a leading UK-based contract development and manufacturing organisation (CDMO), continues its growth following the build of a new sterile manufacturing facility with the appointment of Michael Mellor-Clark as Chief Commercial Officer (CCO). Michael joins the company in a period of sustained growth and expansion and…

Gilbert To Officially Open New Development and GMP Manufacturing Facility

22 March 2024 — Nottingham, UK — UK-based contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions was joined by Oxford/AstraZeneca COVID-19 vaccine co-inventor Professor Dame Sarah Gilbert, biotech industry representatives and local leaders to celebrate the official opening of a new 50,000 square foot development and GMP manufacturing facility in Nottingham, UK. In addition to Professor…